Poland· PL-100291075

Riluzole Zentiva

A riluzole product containing riluzolum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 17 of our 19 countries.

ATC N07XX02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about riluzolumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Riluzole is registered in 17 of 19 countries.

Countries holding a registration under ATC N07XX02 (riluzole), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search riluzole products by name

Riluzole · ATC N07XX02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of riluzole costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $5.62 in France to $9.14 in Italy — a ×1.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Riluzole · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

IT Italy$9.14
CH Switzerland$8.63
FR France$5.62

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Riluzolum
Manufacturer: Zentiva, k.s.
Country: Poland (PL)
ATC code: N07XX02
ATC class: Riluzole
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

gtin
05909991033880

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

46 interactions on record for riluzole.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check riluzole against other medicines How interaction checks work

Riluzole · interactions on record

46 records

4 severe
28 moderate
5 minor
9 info

Most severe, free to view

LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe
TeriflunomideL04AK02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Riluzole in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All riluzole products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Emylif, Riluzol Aristo
Belgium · Emylif, Riluzol Ab
Cyprus · Teglutik
Czechia · Riluzol Pmcs
Germany · Emylif, Glentek
Denmark · Emylif, Glentek
Estonia · Lizolorol, Rilustad
Spain · Emylif, Riluzol Aurovitas
Finland · Teglutik
France · Emylif, Riluzole Arrow
United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
Greece · Teglutik
Croatia · Alsemol
Hungary · Sclefic
Iceland · Emylif, Rilutek
Italy · Emylif, Riluzolo Aurobindo
Liechtenstein · Rilutek, Riluzole Zentiva
Luxembourg · Emylif, Teglutik
Netherlands · Emylif, Glentek
Norway · Emylif, Rilutek
Portugal · Emylif, Riluzol Aurovitas
Romania · Riluzol Pmcs
Sweden · Emylif, Glentek
Slovenia · Sclefic
Slovakia · Riluzol Pmcs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c2d69e50-90cb-4154-a01a-9666b9cdb70f
GET /v1/drugs/c2d69e50-90cb-4154-a01a-9666b9cdb70f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991033880 ¦ Rpz ¦ EU/1/12/768/001 ¦ 50892\n56 tabl.\nRpz ¦ EU/1/12/768/002 ¦ 122773\n28 tabl.\nRpz ¦ EU/1/12/768/003 ¦ 122774\n98 tabl.\nRpz ¦ EU/1/12/768/004 ¦ 122775\n112 tabl.\nRpz ¦ EU/1/12/768/005 ¦ 122776\n168 tabl.",
  "substance": "Riluzolum 50 mg",
  "common_name": "Riluzolum",
  "pl_product_id": "100291075",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

API reference MCP server Plans

See everything about riluzole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console